Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 14, 2025 • 9:00 PM ET

Date/Time Source News Release
06/13/2025 09:00 AM EDT GlobeNewswire GT Biopharma Appoints New Member to its Board of Directors
05/19/2025 09:00 AM EDT GlobeNewswire GT Biopharma Advances GTB-3650 Phase 1 Trial to Cohort 2 Following Successful Initial Human Dosing and Evidence of Early Immune Activation Signals
05/15/2025 09:00 AM EDT GlobeNewswire GT Biopharma Appoints New Member to its Board of Directors
05/14/2025 07:00 AM EDT GlobeNewswire GT Biopharma Appoints New Member to its Board of Directors
03/04/2025 07:00 AM EST GlobeNewswire GT Biopharma to Participate in the 10th Anniversary of the Innate Killer Summit
02/25/2025 02:00 PM EST GlobeNewswire GT Biopharma Announces Exercise of Warrants
02/25/2025 07:00 AM EST GlobeNewswire GT Biopharma Announces Request for Withdrawal of Form S-1 Registration Statement
01/27/2025 07:00 AM EST GlobeNewswire GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-3650, Second-Generation TriKE for the Treatment of Hematologic Malignancies
11/14/2024 04:00 PM EST GlobeNewswire GT Biopharma Reports Third Quarter 2024 Financial Results
09/26/2024 09:15 AM EDT GlobeNewswire GT Biopharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
Page

Additional News

As of June 14, 2025 • 9:00 PM ET

Date/Time Source News Release
06/11/2025 05:48 PM EDT SeekingAlpha GT Biopharma registers 120.6M shares for resale by selling stockholders
05/19/2025 12:02 PM EDT ABN Newswire Ellis Martin Report: GT Biopharma Inc's (NASDAQ:GTBP) Michael Breen: Targeting Cancer Cells with a Natural Killer Based Immunotherapy
05/19/2025 11:15 AM EDT Baystreet Stocks in Play: GT Biopharma, Inc.
05/19/2025 11:10 AM EDT Baystreet This Natural Killer Treatment Could Help Transform How Cancer is Treated
05/17/2025 05:31 AM EDT US Earnings Reports Expected earnings - GT Biopharma Inc.
02/26/2025 04:30 AM EST US Earnings Reports Expected earnings - GT Biopharma Inc.
02/25/2025 08:28 AM EST 24/7 Market News GT Biopharma moves to Withdraw its Form S-1 Registration Statement
12/23/2024 05:36 PM EST SeekingAlpha GT Biopharma files for automatic mixed securities shelf
11/27/2024 04:30 AM EST US Earnings Reports Expected earnings - GT Biopharma Inc.
11/15/2024 04:17 AM EST SeekingAlpha GT Biopharma GAAP EPS of -$1.53
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.